LSD & Acid

LSD therapy, microdosing, dosage guides, legality, and research.

How Psychedelics May Rewire the Brain, According to a Major New Scan Analysis

Researchers combined more than 500 scans and found that psychedelics all pushed the brain toward a similar pattern of activity.

Read More

Trump Signs Executive Order to Accelerate FDA Review of Psychedelic Therapies

Trump framed the order as a response to the mental health crisis facing American veterans. Psychedelic therapy advocates are watching

Read More

New Brain Scan Study Looks At Psychedelics And Emotional Processing

Brain scans are beginning to show a more detailed picture of how regular psychedelic users may process emotional threat. Single

Read More

Definium’s Phase 3 LSD Drug Clears a Major Depression Test

Definium Therapeutics LSD based pill, DT120 ODT, reduced depression symptoms in a phase 3 trial of adults with major depressive

Read More

Surprising Study: LSD Use Makes Losing Your Job Feel Worse

A new study out of Germany says that LSD users have a harder time with losing than job than non-LSD

Read More

Nearly 5 Million Veterans Have Tried Psychedelics, RAND Study Finds

Psychedelics are no longer a fringe topic among veterans. They are part of the lived experience of millions of those

Read More

Researchers Gave Autistic Dogs LSD And It Helped Them Connect Better with Humans

In what could have a groundbreaking impact on the research of psychedelics and autism, this study involving dogs is mind

Read More

Why Some Psychedelic Sessions Turn Frightening. A New Brain Study Offers a Clue

Most people who take a psychedelic under clinical supervision come through the session well. Some do not. A 2026 Stanford

Read More

MindMed Just Dosed Their First Patient in LSD Clinical Trial for Anxiety

We're one step closer. Mindmed just dosed their first patient in their clinical trial using LSD to treat anxiety.

Read More

An Oral LSD Tablet Has Now Cleared Phase 3 Twice This Year. Here Is What Comes Next

An oral LSD tablet has now cleared phase 3 twice in a single year. Definium Therapeutics reported that DT120 ODT

Read More

Explore Psychedelic Therapy Regions